- Home
- NUVL vs BMI Comparison
NUVL vs BMI Comparison
Compare NUVL & BMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVL
- BMI
- Stock Information
- Founded
- NUVL 2017
- BMI 1905
- Country
- NUVL United States
- BMI United States
- Employees
- NUVL N/A
- BMI N/A
- Industry
- NUVL Biotechnology: Pharmaceutical Preparations
- BMI Industrial Machinery/Components
- Sector
- NUVL Health Care
- BMI Industrials
- Exchange
- NUVL Nasdaq
- BMI Nasdaq
- Market Cap
- NUVL 5.5B
- BMI 6.1B
- IPO Year
- NUVL 2021
- BMI N/A
- Fundamental
- Price
- NUVL $79.49
- BMI $210.16
- Analyst Decision
- NUVL Strong Buy
- BMI Buy
- Analyst Count
- NUVL 11
- BMI 6
- Target Price
- NUVL $112.36
- BMI $222.00
- AVG Volume (30 Days)
- NUVL 420.4K
- BMI 226.0K
- Earning Date
- NUVL 03-04-2025
- BMI 04-17-2025
- Dividend Yield
- NUVL N/A
- BMI 0.65%
- EPS Growth
- NUVL N/A
- BMI 34.71
- EPS
- NUVL N/A
- BMI 4.23
- Revenue
- NUVL N/A
- BMI $826,558,000.00
- Revenue This Year
- NUVL N/A
- BMI $12.26
- Revenue Next Year
- NUVL N/A
- BMI $8.64
- P/E Ratio
- NUVL N/A
- BMI $49.70
- Revenue Growth
- NUVL N/A
- BMI 17.48
- 52 Week Low
- NUVL $61.80
- BMI $150.87
- 52 Week High
- NUVL $113.51
- BMI $239.11
- Technical
- Relative Strength Index (RSI)
- NUVL 43.83
- BMI 42.33
- Support Level
- NUVL $77.84
- BMI $212.59
- Resistance Level
- NUVL $85.21
- BMI $221.80
- Average True Range (ATR)
- NUVL 3.78
- BMI 5.32
- MACD
- NUVL -0.46
- BMI -0.01
- Stochastic Oscillator
- NUVL 12.08
- BMI 35.48
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
About BMI Badger Meter Inc.
Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Badger's product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.